As of August 28, 2026, Telix Pharmaceuticals Limited (TLX) has a DilutionWatch DilutionScore of 17/100, rated LOW dilution risk. Telix Pharmaceuticals Limited has a market capitalization of $3.19B, 338.78M shares outstanding, 38 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for TLX.
Market Data
Market Cap$3.19B
Shares Outstanding338.78M
Float273.19M
Cash$141.87M
Debt$467.11M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 130.5% shares (2026Q1 vs prior)
38 institutional holders · 2.59M shares
#1
FMR LLC
564.8K shares
#2
Portolan Capital Management, LLC
541.3K shares
#3
LAZARD ASSET MANAGEMENT LLC
289.9K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest277.7K
Days to Cover2.6
% of Float0.1%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track TLX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TLX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required